Early Access — free while we kick the tires
EdgarHawk

Karp Daniel

Executive VP, Corp. Dev.

Officer
1 filing analyzed · 1 company · Latest 2025-05-07

Companies

Company Buys Sells Direction
Organon & Co. OGN 1 0 Net buying

Activity

May 2025
2025-05-07 Organon & Co. OGN
high
Buy
3,500 shares
$28,828
Significance 7/10

Karp (EVP Corp. Dev.) purchases 3,500 shares of OGN at $8.24; stock down 62.0% from 52-week high as 5 insiders buy in 14 days

Daniel Karp, Executive VP of Corporate Development, purchased 3,500 shares at $8.24 on 2025-05-06, increasing his holdings to 46,669 shares. This transaction occurs within a cluster of 4 other insider purchases in the past 14 days, indicating coordinated or near-simultaneous buying activity. The stock has experienced severe weakness, trading at $8.76 current price against a 52-week high of $23.03 (-62.0%) and declining 30.0% over 30 days and 41.2% over 90 days. The confluence of accumulation by multiple insiders including a corporate development executive during a period of sharp valuation compression is noteworthy; investors should examine whether this reflects assessment of fundamental value at depressed levels or signals awareness of upcoming corporate developments related to Karp's portfolio responsibilities.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access